FACTORS ASSOCIATED WITH LONG-TERM RETENTION OF TREATMENT WITH GOLIMUMAB IN A LARGE COHORT OF PATIENTS WITH RHEUMATIC DISEASES, WITH UP TO 8 YEARS OF FOLLOW-UP

Pombo-Suarez, M; Seoane-Mato, D; Cea-Calvo, L; Diaz-Gonzalez, F; Sanchez-Alonso, F; Sanchez-Jareno, M; Ruiz, FJM; Ruiz, L; Jovani, V; Castrejon, I

ANNALS OF THE RHEUMATIC DISEASES, 2022; 81 (): 773